Insider Trading: Heska Corp (HSKA.OQ)
HSKA.OQ on NASDAQ Stock Exchange Capital Market
6.85USD
17 Jun 2013
6.85USD
17 Jun 2013
Price Change (% chg)
$0.06 (+0.88%)
$0.06 (+0.88%)
Prev Close
$6.79
$6.79
Open
$6.83
$6.83
Day's High
$6.85
$6.85
Day's Low
$6.83
$6.83
Volume
100
100
Avg. Vol
4,432
4,432
52-wk High
$12.00
$12.00
52-wk Low
$6.74
$6.74
MCGINLEY MICHAEL J
| Trading Date | Type | Shares Traded | Price | Shares Held |
|---|---|---|---|---|
| 29 Jan 2013 | Sell | 3,745 | $8.41 | 14,902 |
| 29 Jan 2013 | Buy | 4,500 | $7.00 | 14,902 |
| 25 Mar 2012 | Buy | 10,773 | $4.40 | 13,773 |
| 25 Mar 2012 | Sell | 4,890 | $11.78 | 13,773 |
| 25 Mar 2012 | Buy | 3,000 | $3.40 | 13,773 |
Institutional Holders
| % Shares Owned: | 29.86% |
| # of Holders: | 33 |
| Total Shares Held: | 1,733,064 |
| 3 Mo. Net Change: | 4,896 |
| # New Positions: | 2 |
| # Closed Positions: | 3 |
| # Increased Positions: | 12 |
| # Reduced Positions: | 12 |
| # Net Buyers: | 0 |
Officers & Directors
| Name | Age | Since | Current Position |
|---|---|---|---|
Robert Grieve |
61 | 2000 | Chairman of the Board, Chief Executive Officer |
Kevin Wilson |
41 | 2013 | President, Chief Operating Officer |
Jason Napolitano |
44 | 2009 | Chief Financial Officer, Executive Vice President, Secretary |
Michael McGinley |
52 | 2013 | President - Biologicals & Pharmaceuticals |
Steven Asakowicz |
47 | 2013 | Executive Vice President - Companion Animal Health Sales |
Rodney Lippincott |
39 | 2013 | Executive Vice President - Companion Animal Health Sales |
Nancy Wisnewski |
50 | 2011 | Executive Vice President - Product Development and Customer Support |
Michael Bent |
58 | 2002 | Vice President, Principal Accounting Officer, Controller |
William Aylesworth |
70 | 2010 | Lead Independent Director |
Peter Eio |
71 | 2002 | Independent Director |
G. Irwin Gordon |
62 | 2001 | Independent Director |
Sharon Riley |
52 | 2011 | Independent Director |
Carol Wrenn |
52 | 2013 | Independent Director |

